An Australian dog named Rosie received a life-extending cancer treatment developed with AI, but scientists warn outdated regulations are hindering Australia's potential to lead in AI-driven precision medicine.
A dog named Rosie's cancer treatment, aided by AI, has demonstrated the potential of personalized medicine. However, outdated regulations in Australia are hindering the adoption of such advanced AI-driven therapies for both humans and animals.
An Australian dog named Rosie received an AI-assisted mRNA vaccine that significantly shrunk her tumors, extending her life. Scientists at UNSW used AI to process genetic data, fast-tracking treatment design from years to months. However, outdated regulatory frameworks in Australia are seen as a major obstacle to adopting such AI-driven precision medicine for humans.
A new mRNA vaccine, Intessemiran Autogen, combined with immunotherapy, has shown a 49% reduction in skin cancer recurrence or death in Stage III/IV patients. The vaccine analyzes tumor mutations to train the immune system.
A personalized mRNA vaccine combined with Keytruda significantly reduced the risk of melanoma recurrence and death in a clinical trial. The therapy, which trains T cells to target unique tumor neoantigens, showed 68.8% of patients remained cancer-free after five years, compared to 49.1% with Keytruda alone.
